Monsenso A/S (CPH:MONSO)
Denmark · Delayed Price · Currency is DKK 0.1900
+0.0350 (22.58%)
May 6, 2026, 4:59 PM CET
Monsenso Market Cap
Monsenso has a market cap or net worth of 10.35 million as of May 6, 2026. Its market cap has decreased by -41.17% in one year.
Market Cap
10.35M
Enterprise Value
12.14M
Revenue
8.91M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.19
Market Cap Chart
Since June 10, 2020, Monsenso's market cap has decreased from 96.87M to 10.35M, a decrease of -89.32%. That is a compound annual growth rate of -31.53%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 5, 2026 | 10.35M | 3.33% |
| Dec 30, 2025 | 10.02M | -59.16% |
| Dec 30, 2024 | 24.52M | 177.63% |
| Dec 29, 2023 | 8.83M | -21.75% |
| Dec 30, 2022 | 11.29M | -59.30% |
| Dec 30, 2021 | 27.73M | -82.99% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Jun 10, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Novo Nordisk | 1.23T |
| Genmab | 104.00B |
| Coloplast | 90.70B |
| ALK-Abelló | 53.62B |
| Gubra | 5.24B |
| BioPorto | 613.94M |
| ViroGates | 104.89M |
| Pharma Equity Group | 104.59M |